Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma

por Wu, Liviawati S., Su, Yaming, Li, Claire, Zhou, Wangda, Jackson, Carolyn C., Sun, Yu‐Nien, Zhou, Honghui
Publicado 2022

Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV‐8

por Jackson, Carolyn C., Dickson, Mark A., Sadjadi, Mahan, Gessain, Antoine, Abel, Laurent, Jouanguy, Emmanuelle, Casanova, Jean‐Laurent
Publicado 2015

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma

por Jagannath, Sundar, Joseph, Nedra, Crivera, Concetta, Kharat, Akshay, Jackson, Carolyn C., Valluri, Satish, Cost, Patricia, Phelps, Hilary, Slowik, Rafal, Klein, Timothy, Smolen, Lee, Yu, Xueting, Cohen, Adam D.
Publicado 2023

The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies

por Crawford, Rebecca, Gries, Katharine S., Valluri, Satish, Fastenau, John, Morrison, Ross, Yeh, Tzu‐Min, Olyslager, Yunsi, Goldberg, Jenna D., Schecter, Jordan M., Jackson, Carolyn C., Deraedt, William, Doward, Lynda
Publicado 2022

Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort

por Ri, Masaki, Suzuki, Kenshi, Ishida, Tadao, Kuroda, Junya, Tsukamoto, Taku, Teshima, Takanori, Goto, Hideki, Jackson, Carolyn C., Sun, Huabin, Pacaud, Lida, Fujikawa, Ei, Yeh, Tzu‐Min, Hatayama, Tomoyoshi, Aida, Kensuke, Sunagawa, Yoshihiro, Iida, Shinsuke
Publicado 2022

Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry

por Merz, Maximilian, Goldschmidt, Hartmut, Hari, Parameswaran, Agha, Mounzer, Diels, Joris, Ghilotti, Francesca, Perualila, Nolen J., Cabrieto, Jedelyn, Haefliger, Benjamin, Sliwka, Henrik, Schecter, Jordan M., Jackson, Carolyn C., Olyslager, Yunsi, Akram, Muhammad, Nesheiwat, Tonia, Kellermann, Lenka, Jagannath, Sundar
Publicado 2021

Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment...

por Martin, Thomas, Krishnan, Amrita, Yong, Kwee, Weisel, Katja, Mehra, Maneesha, Nair, Sandhya, Qi, Keqin, Londhe, Anil, Diels, Joris, Crivera, Concetta, Jackson, Carolyn C., Olyslager, Yunsi, Vogel, Martin, Schecter, Jordan M., Banerjee, Arnob, Valluri, Satish, Usmani, Saad Z., Berdeja, Jesus G., Jagannath, Sundar
Publicado 2021

S202: CARTITUDE-1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

por Munshi, Nikhil, Martin, Tom, Usmani, Saad Z, Berdeja, Jesus, Jakubowiak, Andrzej, Agha, Mounzer, Cohen, Adam D, Deol, Abhinav, Htut, Myo, Lesokhin, Alexander, Lin, Yi, O’donnell, Elizabeth, Jackson, Carolyn C, Yeh, Tzu-Min, Banerjee, Arnob, Zudaire, Enrique, Madduri, Deepu, Delcorral, Christopher, Pacaud, Lida, Jagannath, Sundar
Publicado 2023

P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTI...

por Mateos, Maria-Victoria, Weisel, Katja, Martin, Tom, Berdeja, Jesus, Jakubowiak, Andrzej, Stewart, Keith, Jagannath, Sundar, Lin, Yi, Diels, Joris, Ghilotti, Francesca, Thilakarathne, Pushpike, Perualila, Nolen, Cabrieto, Jedelyn, Erler-Yates, Nichola, Jackson, Carolyn C, Schecter, Jordan, Strulev, Vadim, Haddad, Imene, Costa Filho, Octavio, Pacaud, Lida, Einsele, Hermann, Moreau, Philippe
Publicado 2023

Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD3...

por Mateos, Maria-Victoria, Weisel, Katja, Martin, Thomas, Berdeja, Jesús G., Jakubowiak, Andrzej, Stewart, A. Keith, Jagannath, Sundar, Lin, Yi, Diels, Joris, Ghilotti, Francesca, Thilakarathne, Pushpike, Perualila, Nolen J., Cabrieto, Jedelyn, Haefliger, Benjamin, Erler-Yates, Nichola, Hague, Clare, Jackson, Carolyn C., Schecter, Jordan M., Strulev, Vadim, Nesheiwat, Tonia, Pacaud, Lida, Einsele, Hermann, Moreau, Philippe
Publicado 2022

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

por Raghunandan, Sharmila, Pauly, Melinda, Blum, William G, Qayed, Muna, Dhodapkar, Madhav V, Elkhalifa, Mohamed, Watkins, Benjamin, Schoettler, Michelle, Horwitz, Edwin, Parikh, Suhag, Chandrakasan, Shanmuganathan, Leung, Kathryn, Bryson, Elyse, Deeb, Laura, Kaufman, Jonathan L, Worthington-White, Diana, Alazraki, Adina, Schecter, Jordan M, Madduri, Deepu, Jackson, Carolyn C, Zudaire, Enrique, Taraseviciute-Morris, Agne, Babich, Alexander, Nesheiwat, Tonia, Vogel, Martin, Lendvai, Nikoletta, Pacaud, Lida, Williams, Kirsten M
Publicado 2023

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

por Cohen, Adam D., Parekh, Samir, Santomasso, Bianca D., Gállego Pérez-Larraya, Jaime, van de Donk, Niels W. C. J., Arnulf, Bertrand, Mateos, Maria-Victoria, Lendvai, Nikoletta, Jackson, Carolyn C., De Braganca, Kevin C., Schecter, Jordan M., Marquez, Loreta, Lee, Erin, Cornax, Ingrid, Zudaire, Enrique, Li, Claire, Olyslager, Yunsi, Madduri, Deepu, Varsos, Helen, Pacaud, Lida, Akram, Muhammad, Geng, Dong, Jakubowiak, Andrzej, Einsele, Hermann, Jagannath, Sundar
Publicado 2022

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

por Martin, Thomas, Usmani, Saad Z., Berdeja, Jesus G., Agha, Mounzer, Cohen, Adam D., Hari, Parameswaran, Avigan, David, Deol, Abhinav, Htut, Myo, Lesokhin, Alexander, Munshi, Nikhil C., O'Donnell, Elizabeth, Stewart, A. Keith, Schecter, Jordan M., Goldberg, Jenna D., Jackson, Carolyn C., Yeh, Tzu-Min, Banerjee, Arnob, Allred, Alicia, Zudaire, Enrique, Deraedt, William, Olyslager, Yunsi, Zhou, Changwei, Pacaud, Lida, Madduri, Deepu, Jakubowiak, Andrzej, Lin, Yi, Jagannath, Sundar
Publicado 2023